EMERGING TRENDS IN CANCER IMMUNOTHERAPY: OPPORTUNITIES AND CHALLENGES
DOI:
https://doi.org/10.71465/mrcis123Keywords:
Cancer Immunotherapy, Immune Checkpoint Inhibitors, CAR-T Therapy, Cancer Vaccines, Oncology, PakistanAbstract
Cancer immunotherapy has revolutionized the landscape of oncology, offering promising avenues for the treatment of various malignancies. This article provides an in-depth analysis of the emerging trends in cancer immunotherapy, focusing on the advancements, opportunities, and challenges within the Pakistani context. We explore the mechanisms of immune checkpoint inhibitors, chimeric antigen receptor T-cell therapy (CAR-T), and cancer vaccines, highlighting their clinical applications and efficacy. Additionally, the article addresses the challenges faced in the implementation of these therapies in Pakistan, including infrastructural limitations, high treatment costs, and the need for specialized training. By examining the current landscape, we aim to provide insights into the future directions of cancer immunotherapy in Pakistan and the potential strategies to overcome existing barriers.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Munira Shabbir Moosajee, Muhammad Jawad Khan (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
All articles published in the Multidisciplinary Research in Computing Information Systems are licensed under an open-access model. Authors retain full copyright and grant the journal the right of first publication. The content can be freely accessed, distributed, and reused for non-commercial purposes, provided proper citation is given to the original work.
